The stock of Outset Medical Inc (OM) has gone up by 5.78% for the week, with a 8.18% rise in the past month and a -31.21% drop in the past quarter. The volatility ratio for the week is 7.68%, and the volatility levels for the past 30 days are 9.57% for OM. The simple moving average for the last 20 days is 7.18% for OM’s stock, with a simple moving average of -67.81% for the last 200 days.
Is It Worth Investing in Outset Medical Inc (NASDAQ: OM) Right Now?
Company’s 36-month beta value is 1.86.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OM is 46.36M, and currently, short sellers hold a 18.51% ratio of that floaft. The average trading volume of OM on April 26, 2024 was 959.46K shares.
OM) stock’s latest price update
Outset Medical Inc (NASDAQ: OM)’s stock price has dropped by -6.67 in relation to previous closing price of 2.55. Nevertheless, the company has seen a gain of 5.78% in its stock price over the last five trading days. Business Wire reported 2024-04-19 that SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the close of trading on Wednesday, May 8, 2024. On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer,.
Analysts’ Opinion of OM
Many brokerage firms have already submitted their reports for OM stocks, with BTIG Research repeating the rating for OM by listing it as a “Buy.” The predicted price for OM in the upcoming period, according to BTIG Research is $6 based on the research report published on April 08, 2024 of the current year 2024.
CL King, on the other hand, stated in their research note that they expect to see OM reach a price target of $6. The rating they have provided for OM stocks is “Buy” according to the report published on April 05th, 2024.
RBC Capital Mkts gave a rating of “Sector Perform” to OM, setting the target price at $6 in the report published on January 12th of the current year.
OM Trading at -8.52% from the 50-Day Moving Average
After a stumble in the market that brought OM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.14% of loss for the given period.
Volatility was left at 9.57%, however, over the last 30 days, the volatility rate increased by 7.68%, as shares surge +8.18% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.68% lower at present.
During the last 5 trading sessions, OM rose by +5.78%, which changed the moving average for the period of 200-days by -88.17% in comparison to the 20-day moving average, which settled at $2.23. In addition, Outset Medical Inc saw -56.01% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OM starting from Nash Marc, who sale 2,391 shares at the price of $2.13 back on Mar 15 ’24. After this action, Nash Marc now owns 242,510 shares of Outset Medical Inc, valued at $5,093 using the latest closing price.
Ahmed Nabeel, the Chief Financial Officer of Outset Medical Inc, sale 1,584 shares at $3.15 during a trade that took place back on Mar 01 ’24, which means that Ahmed Nabeel is holding 322,877 shares at $4,990 based on the most recent closing price.
Stock Fundamentals for OM
Current profitability levels for the company are sitting at:
- -1.3 for the present operating margin
- 0.22 for the gross margin
The net margin for Outset Medical Inc stands at -1.33. The total capital return value is set at -0.66. Equity return is now at value -93.69, with -48.41 for asset returns.
Based on Outset Medical Inc (OM), the company’s capital structure generated 0.53 points at debt to capital in total, while cash flow to debt ratio is standing at -0.96. The debt to equity ratio resting at 1.11. The interest coverage ratio of the stock is -13.39.
Currently, EBITDA for the company is -153.79 million with net debt to EBITDA at -0.43. When we switch over and look at the enterprise to sales, we see a ratio of 1.44. The receivables turnover for the company is 3.95for trailing twelve months and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.26.
Conclusion
In a nutshell, Outset Medical Inc (OM) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
